FASLG and autoimmune polyendocrinopathy: The GAPSS score, which is a clinically validated tool to predict the risk of thrombosis in APS patients, includes both hypertension and dyslipidemia, along with the presence of aPL, as independent determinants of thrombosis risk in APS [6].